Masimo Corporation (MASI)

NASDAQ: MASI · Real-Time Price · USD

164.26

3.30 (2.05%)

At close: May 01, 2025, 11:20 AM

2.05% (1D)

Bid	163.91
Market Cap	8.88B
Revenue (ttm)	2.09B
Net Income (ttm)	-304.9M
EPS (ttm)	-5.73
PE Ratio (ttm)	-28.67
Forward PE	27.31
Analyst	Buy

Ask	164.41
Volume	153,359
Avg. Volume (20D)	581,934
Open	163.54
Previous Close	160.96
Day's Range	160.91 - 164.53
52-Week Range	101.61 - 194.88
Beta	1.28

About MASI

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products t...

Sector Healthcare

IPO Date Aug 8, 2007

Employees 3,600

Stock Exchange NASDAQ

Ticker Symbol MASI

Website https://www.masimo.com

Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $194, which is an increase of 18.11% from the latest price.

Stock Forecasts

Next Earnings Release

Masimo Corporation is scheduled to release its earnings on May 6, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+12.35%

Masimo shares are trading higher after the company... Unlock content with Pro Subscription

7 months ago

+6.02%

Masimo Corp shares are trading higher after the company provided updates on its leadership and business.

News

2 days ago · seekingalpha.com

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...

1 week ago · zacks.com

Why Masimo (MASI) Could Beat Earnings Estimates Again

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 weeks ago · zacks.com

Why You Shouldn't Bet Against Masimo (MASI) Stock

Masimo (MASI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

3 weeks ago · zacks.com

Here's Why Masimo (MASI) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

4 weeks ago · zacks.com

3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.

4 weeks ago · zacks.com

Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why

Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

4 weeks ago · businesswire.com

Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2:15...